Global Clinical Oncology Next Generation Sequencing (NGS) Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Clinical Oncology Next Generation Sequencing (NGS) market size was valued at US$ 689.3 million in 2023. With growing demand in downstream market, the Clinical Oncology Next Generation Sequencing (NGS) is forecast to a readjusted size of US$ 1427.1 million by 2030 with a CAGR of 11.0% during review period.
The research report highlights the growth potential of the global Clinical Oncology Next Generation Sequencing (NGS) market. Clinical Oncology Next Generation Sequencing (NGS) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Clinical Oncology Next Generation Sequencing (NGS). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Clinical Oncology Next Generation Sequencing (NGS) market.
NGS allows the testing of all types of variants including single-nucleotide variations, insertions, deletions, exon duplications, gene copy number changes and translocations.
The key factor contributing to the growth of the NGS market is the improved understanding of the genetic markers of virulence and resistance.
Key Features:
The report on Clinical Oncology Next Generation Sequencing (NGS) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Clinical Oncology Next Generation Sequencing (NGS) market. It may include historical data, market segmentation by Type (e.g., NGS Pre-Sequencing, Sequencing), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Clinical Oncology Next Generation Sequencing (NGS) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Clinical Oncology Next Generation Sequencing (NGS) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Clinical Oncology Next Generation Sequencing (NGS) industry. This include advancements in Clinical Oncology Next Generation Sequencing (NGS) technology, Clinical Oncology Next Generation Sequencing (NGS) new entrants, Clinical Oncology Next Generation Sequencing (NGS) new investment, and other innovations that are shaping the future of Clinical Oncology Next Generation Sequencing (NGS).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Clinical Oncology Next Generation Sequencing (NGS) market. It includes factors influencing customer ' purchasing decisions, preferences for Clinical Oncology Next Generation Sequencing (NGS) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Clinical Oncology Next Generation Sequencing (NGS) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Clinical Oncology Next Generation Sequencing (NGS) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Clinical Oncology Next Generation Sequencing (NGS) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Clinical Oncology Next Generation Sequencing (NGS) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Clinical Oncology Next Generation Sequencing (NGS) market.
Market Segmentation:
Clinical Oncology Next Generation Sequencing (NGS) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Clinical Oncology Next Generation Sequencing (NGS) market size was valued at US$ 689.3 million in 2023. With growing demand in downstream market, the Clinical Oncology Next Generation Sequencing (NGS) is forecast to a readjusted size of US$ 1427.1 million by 2030 with a CAGR of 11.0% during review period.
The research report highlights the growth potential of the global Clinical Oncology Next Generation Sequencing (NGS) market. Clinical Oncology Next Generation Sequencing (NGS) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Clinical Oncology Next Generation Sequencing (NGS). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Clinical Oncology Next Generation Sequencing (NGS) market.
NGS allows the testing of all types of variants including single-nucleotide variations, insertions, deletions, exon duplications, gene copy number changes and translocations.
The key factor contributing to the growth of the NGS market is the improved understanding of the genetic markers of virulence and resistance.
Key Features:
The report on Clinical Oncology Next Generation Sequencing (NGS) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Clinical Oncology Next Generation Sequencing (NGS) market. It may include historical data, market segmentation by Type (e.g., NGS Pre-Sequencing, Sequencing), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Clinical Oncology Next Generation Sequencing (NGS) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Clinical Oncology Next Generation Sequencing (NGS) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Clinical Oncology Next Generation Sequencing (NGS) industry. This include advancements in Clinical Oncology Next Generation Sequencing (NGS) technology, Clinical Oncology Next Generation Sequencing (NGS) new entrants, Clinical Oncology Next Generation Sequencing (NGS) new investment, and other innovations that are shaping the future of Clinical Oncology Next Generation Sequencing (NGS).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Clinical Oncology Next Generation Sequencing (NGS) market. It includes factors influencing customer ' purchasing decisions, preferences for Clinical Oncology Next Generation Sequencing (NGS) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Clinical Oncology Next Generation Sequencing (NGS) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Clinical Oncology Next Generation Sequencing (NGS) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Clinical Oncology Next Generation Sequencing (NGS) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Clinical Oncology Next Generation Sequencing (NGS) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Clinical Oncology Next Generation Sequencing (NGS) market.
Market Segmentation:
Clinical Oncology Next Generation Sequencing (NGS) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- NGS Pre-Sequencing
- Sequencing
- NGS Data Analysis
- Primary, Secondary & Tertiary Data Analysis
- Academic & Clinical Research
- Hospitals & Clinics
- Pharma & Biotech Entities
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Illumina
- Roche
- Agilent Technologies
- Knome
- Genomatix Software
- GATC Biotech
- Oxford Nanopore Technologies
- Macrogen
- Life Technologies
- DNASTAR
- Exosome Diagnostics
- Biomatters
- CLC Bio
- BGI
- Qiagen
- Perkin Elmer
- Pacific Bioscience
- Partek
- GnuBIO
- Foundation Medicine
- Paradigm
- Caris Life Sciences
- Myriad Genetics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size 2019-2030
2.1.2 Clinical Oncology Next Generation Sequencing (NGS) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Clinical Oncology Next Generation Sequencing (NGS) Segment by Type
2.2.1 NGS Pre-Sequencing
2.2.2 Sequencing
2.2.3 NGS Data Analysis
2.2.4 Primary, Secondary & Tertiary Data Analysis
2.3 Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
2.3.1 Clinical Oncology Next Generation Sequencing (NGS) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2019-2024)
2.4 Clinical Oncology Next Generation Sequencing (NGS) Segment by Application
2.4.1 Academic & Clinical Research
2.4.2 Hospitals & Clinics
2.4.3 Pharma & Biotech Entities
2.5 Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
2.5.1 Clinical Oncology Next Generation Sequencing (NGS) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2019-2024)
3 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET SIZE BY PLAYER
3.1 Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Players
3.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue by Players (2019-2024)
3.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Players (2019-2024)
3.2 Global Clinical Oncology Next Generation Sequencing (NGS) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) BY REGIONS
4.1 Clinical Oncology Next Generation Sequencing (NGS) Market Size by Regions (2019-2024)
4.2 Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth (2019-2024)
4.3 APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth (2019-2024)
4.4 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth (2019-2024)
4.5 Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2019-2024)
5.2 Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2019-2024)
5.3 Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (2019-2024)
6.2 APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2019-2024)
6.3 APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Clinical Oncology Next Generation Sequencing (NGS) by Country (2019-2024)
7.2 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2019-2024)
7.3 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) by Region (2019-2024)
8.2 Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2019-2024)
8.3 Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET FORECAST
10.1 Global Clinical Oncology Next Generation Sequencing (NGS) Forecast by Regions (2025-2030)
10.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Forecast by Regions (2025-2030)
10.1.2 Americas Clinical Oncology Next Generation Sequencing (NGS) Forecast
10.1.3 APAC Clinical Oncology Next Generation Sequencing (NGS) Forecast
10.1.4 Europe Clinical Oncology Next Generation Sequencing (NGS) Forecast
10.1.5 Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Forecast
10.2 Americas Clinical Oncology Next Generation Sequencing (NGS) Forecast by Country (2025-2030)
10.2.1 United States Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.2.2 Canada Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.2.3 Mexico Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.2.4 Brazil Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.3 APAC Clinical Oncology Next Generation Sequencing (NGS) Forecast by Region (2025-2030)
10.3.1 China Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.3.2 Japan Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.3.3 Korea Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.3.4 Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.3.5 India Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.3.6 Australia Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.4 Europe Clinical Oncology Next Generation Sequencing (NGS) Forecast by Country (2025-2030)
10.4.1 Germany Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.4.2 France Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.4.3 UK Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.4.4 Italy Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.4.5 Russia Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.5 Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Forecast by Region (2025-2030)
10.5.1 Egypt Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.5.2 South Africa Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.5.3 Israel Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.5.4 Turkey Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.5.5 GCC Countries Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.6 Global Clinical Oncology Next Generation Sequencing (NGS) Forecast by Type (2025-2030)
10.7 Global Clinical Oncology Next Generation Sequencing (NGS) Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Illumina
11.1.1 Illumina Company Information
11.1.2 Illumina Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.1.3 Illumina Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Illumina Main Business Overview
11.1.5 Illumina Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.2.3 Roche Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Information
11.3.2 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.3.3 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Agilent Technologies Main Business Overview
11.3.5 Agilent Technologies Latest Developments
11.4 Knome
11.4.1 Knome Company Information
11.4.2 Knome Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.4.3 Knome Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Knome Main Business Overview
11.4.5 Knome Latest Developments
11.5 Genomatix Software
11.5.1 Genomatix Software Company Information
11.5.2 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.5.3 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Genomatix Software Main Business Overview
11.5.5 Genomatix Software Latest Developments
11.6 GATC Biotech
11.6.1 GATC Biotech Company Information
11.6.2 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.6.3 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 GATC Biotech Main Business Overview
11.6.5 GATC Biotech Latest Developments
11.7 Oxford Nanopore Technologies
11.7.1 Oxford Nanopore Technologies Company Information
11.7.2 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.7.3 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Oxford Nanopore Technologies Main Business Overview
11.7.5 Oxford Nanopore Technologies Latest Developments
11.8 Macrogen
11.8.1 Macrogen Company Information
11.8.2 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.8.3 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Macrogen Main Business Overview
11.8.5 Macrogen Latest Developments
11.9 Life Technologies
11.9.1 Life Technologies Company Information
11.9.2 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.9.3 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Life Technologies Main Business Overview
11.9.5 Life Technologies Latest Developments
11.10 DNASTAR
11.10.1 DNASTAR Company Information
11.10.2 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.10.3 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 DNASTAR Main Business Overview
11.10.5 DNASTAR Latest Developments
11.11 Exosome Diagnostics
11.11.1 Exosome Diagnostics Company Information
11.11.2 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.11.3 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Exosome Diagnostics Main Business Overview
11.11.5 Exosome Diagnostics Latest Developments
11.12 Biomatters
11.12.1 Biomatters Company Information
11.12.2 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.12.3 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Biomatters Main Business Overview
11.12.5 Biomatters Latest Developments
11.13 CLC Bio
11.13.1 CLC Bio Company Information
11.13.2 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.13.3 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 CLC Bio Main Business Overview
11.13.5 CLC Bio Latest Developments
11.14 BGI
11.14.1 BGI Company Information
11.14.2 BGI Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.14.3 BGI Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 BGI Main Business Overview
11.14.5 BGI Latest Developments
11.15 Qiagen
11.15.1 Qiagen Company Information
11.15.2 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.15.3 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Qiagen Main Business Overview
11.15.5 Qiagen Latest Developments
11.16 Perkin Elmer
11.16.1 Perkin Elmer Company Information
11.16.2 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.16.3 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Perkin Elmer Main Business Overview
11.16.5 Perkin Elmer Latest Developments
11.17 Pacific Bioscience
11.17.1 Pacific Bioscience Company Information
11.17.2 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.17.3 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Pacific Bioscience Main Business Overview
11.17.5 Pacific Bioscience Latest Developments
11.18 Partek
11.18.1 Partek Company Information
11.18.2 Partek Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.18.3 Partek Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Partek Main Business Overview
11.18.5 Partek Latest Developments
11.19 GnuBIO
11.19.1 GnuBIO Company Information
11.19.2 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.19.3 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 GnuBIO Main Business Overview
11.19.5 GnuBIO Latest Developments
11.20 Foundation Medicine
11.20.1 Foundation Medicine Company Information
11.20.2 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.20.3 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Foundation Medicine Main Business Overview
11.20.5 Foundation Medicine Latest Developments
11.21 Paradigm
11.21.1 Paradigm Company Information
11.21.2 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.21.3 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Paradigm Main Business Overview
11.21.5 Paradigm Latest Developments
11.22 Caris Life Sciences
11.22.1 Caris Life Sciences Company Information
11.22.2 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.22.3 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 Caris Life Sciences Main Business Overview
11.22.5 Caris Life Sciences Latest Developments
11.23 Myriad Genetics
11.23.1 Myriad Genetics Company Information
11.23.2 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.23.3 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.23.4 Myriad Genetics Main Business Overview
11.23.5 Myriad Genetics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size 2019-2030
2.1.2 Clinical Oncology Next Generation Sequencing (NGS) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Clinical Oncology Next Generation Sequencing (NGS) Segment by Type
2.2.1 NGS Pre-Sequencing
2.2.2 Sequencing
2.2.3 NGS Data Analysis
2.2.4 Primary, Secondary & Tertiary Data Analysis
2.3 Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
2.3.1 Clinical Oncology Next Generation Sequencing (NGS) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2019-2024)
2.4 Clinical Oncology Next Generation Sequencing (NGS) Segment by Application
2.4.1 Academic & Clinical Research
2.4.2 Hospitals & Clinics
2.4.3 Pharma & Biotech Entities
2.5 Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
2.5.1 Clinical Oncology Next Generation Sequencing (NGS) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2019-2024)
3 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET SIZE BY PLAYER
3.1 Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Players
3.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue by Players (2019-2024)
3.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Players (2019-2024)
3.2 Global Clinical Oncology Next Generation Sequencing (NGS) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) BY REGIONS
4.1 Clinical Oncology Next Generation Sequencing (NGS) Market Size by Regions (2019-2024)
4.2 Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth (2019-2024)
4.3 APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth (2019-2024)
4.4 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth (2019-2024)
4.5 Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2019-2024)
5.2 Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2019-2024)
5.3 Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (2019-2024)
6.2 APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2019-2024)
6.3 APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Clinical Oncology Next Generation Sequencing (NGS) by Country (2019-2024)
7.2 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2019-2024)
7.3 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) by Region (2019-2024)
8.2 Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2019-2024)
8.3 Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET FORECAST
10.1 Global Clinical Oncology Next Generation Sequencing (NGS) Forecast by Regions (2025-2030)
10.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Forecast by Regions (2025-2030)
10.1.2 Americas Clinical Oncology Next Generation Sequencing (NGS) Forecast
10.1.3 APAC Clinical Oncology Next Generation Sequencing (NGS) Forecast
10.1.4 Europe Clinical Oncology Next Generation Sequencing (NGS) Forecast
10.1.5 Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Forecast
10.2 Americas Clinical Oncology Next Generation Sequencing (NGS) Forecast by Country (2025-2030)
10.2.1 United States Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.2.2 Canada Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.2.3 Mexico Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.2.4 Brazil Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.3 APAC Clinical Oncology Next Generation Sequencing (NGS) Forecast by Region (2025-2030)
10.3.1 China Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.3.2 Japan Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.3.3 Korea Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.3.4 Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.3.5 India Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.3.6 Australia Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.4 Europe Clinical Oncology Next Generation Sequencing (NGS) Forecast by Country (2025-2030)
10.4.1 Germany Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.4.2 France Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.4.3 UK Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.4.4 Italy Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.4.5 Russia Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.5 Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Forecast by Region (2025-2030)
10.5.1 Egypt Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.5.2 South Africa Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.5.3 Israel Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.5.4 Turkey Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.5.5 GCC Countries Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.6 Global Clinical Oncology Next Generation Sequencing (NGS) Forecast by Type (2025-2030)
10.7 Global Clinical Oncology Next Generation Sequencing (NGS) Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Illumina
11.1.1 Illumina Company Information
11.1.2 Illumina Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.1.3 Illumina Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Illumina Main Business Overview
11.1.5 Illumina Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.2.3 Roche Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Information
11.3.2 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.3.3 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Agilent Technologies Main Business Overview
11.3.5 Agilent Technologies Latest Developments
11.4 Knome
11.4.1 Knome Company Information
11.4.2 Knome Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.4.3 Knome Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Knome Main Business Overview
11.4.5 Knome Latest Developments
11.5 Genomatix Software
11.5.1 Genomatix Software Company Information
11.5.2 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.5.3 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Genomatix Software Main Business Overview
11.5.5 Genomatix Software Latest Developments
11.6 GATC Biotech
11.6.1 GATC Biotech Company Information
11.6.2 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.6.3 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 GATC Biotech Main Business Overview
11.6.5 GATC Biotech Latest Developments
11.7 Oxford Nanopore Technologies
11.7.1 Oxford Nanopore Technologies Company Information
11.7.2 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.7.3 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Oxford Nanopore Technologies Main Business Overview
11.7.5 Oxford Nanopore Technologies Latest Developments
11.8 Macrogen
11.8.1 Macrogen Company Information
11.8.2 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.8.3 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Macrogen Main Business Overview
11.8.5 Macrogen Latest Developments
11.9 Life Technologies
11.9.1 Life Technologies Company Information
11.9.2 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.9.3 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Life Technologies Main Business Overview
11.9.5 Life Technologies Latest Developments
11.10 DNASTAR
11.10.1 DNASTAR Company Information
11.10.2 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.10.3 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 DNASTAR Main Business Overview
11.10.5 DNASTAR Latest Developments
11.11 Exosome Diagnostics
11.11.1 Exosome Diagnostics Company Information
11.11.2 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.11.3 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Exosome Diagnostics Main Business Overview
11.11.5 Exosome Diagnostics Latest Developments
11.12 Biomatters
11.12.1 Biomatters Company Information
11.12.2 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.12.3 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Biomatters Main Business Overview
11.12.5 Biomatters Latest Developments
11.13 CLC Bio
11.13.1 CLC Bio Company Information
11.13.2 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.13.3 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 CLC Bio Main Business Overview
11.13.5 CLC Bio Latest Developments
11.14 BGI
11.14.1 BGI Company Information
11.14.2 BGI Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.14.3 BGI Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 BGI Main Business Overview
11.14.5 BGI Latest Developments
11.15 Qiagen
11.15.1 Qiagen Company Information
11.15.2 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.15.3 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Qiagen Main Business Overview
11.15.5 Qiagen Latest Developments
11.16 Perkin Elmer
11.16.1 Perkin Elmer Company Information
11.16.2 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.16.3 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Perkin Elmer Main Business Overview
11.16.5 Perkin Elmer Latest Developments
11.17 Pacific Bioscience
11.17.1 Pacific Bioscience Company Information
11.17.2 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.17.3 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Pacific Bioscience Main Business Overview
11.17.5 Pacific Bioscience Latest Developments
11.18 Partek
11.18.1 Partek Company Information
11.18.2 Partek Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.18.3 Partek Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Partek Main Business Overview
11.18.5 Partek Latest Developments
11.19 GnuBIO
11.19.1 GnuBIO Company Information
11.19.2 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.19.3 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 GnuBIO Main Business Overview
11.19.5 GnuBIO Latest Developments
11.20 Foundation Medicine
11.20.1 Foundation Medicine Company Information
11.20.2 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.20.3 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Foundation Medicine Main Business Overview
11.20.5 Foundation Medicine Latest Developments
11.21 Paradigm
11.21.1 Paradigm Company Information
11.21.2 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.21.3 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Paradigm Main Business Overview
11.21.5 Paradigm Latest Developments
11.22 Caris Life Sciences
11.22.1 Caris Life Sciences Company Information
11.22.2 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.22.3 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 Caris Life Sciences Main Business Overview
11.22.5 Caris Life Sciences Latest Developments
11.23 Myriad Genetics
11.23.1 Myriad Genetics Company Information
11.23.2 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.23.3 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2019-2024)
11.23.4 Myriad Genetics Main Business Overview
11.23.5 Myriad Genetics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Clinical Oncology Next Generation Sequencing (NGS) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of NGS Pre-Sequencing
Table 3. Major Players of Sequencing
Table 4. Major Players of NGS Data Analysis
Table 5. Major Players of Primary, Secondary & Tertiary Data Analysis
Table 6. Clinical Oncology Next Generation Sequencing (NGS) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2019-2024)
Table 9. Clinical Oncology Next Generation Sequencing (NGS) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2019-2024)
Table 12. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Player (2019-2024)
Table 14. Clinical Oncology Next Generation Sequencing (NGS) Key Players Head office and Products Offered
Table 15. Clinical Oncology Next Generation Sequencing (NGS) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Regions (2019-2024)
Table 20. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Country (2019-2024)
Table 24. Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2019-2024)
Table 26. Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2019-2024)
Table 28. APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Region (2019-2024)
Table 30. APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2019-2024)
Table 32. APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2019-2024)
Table 34. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Country (2019-2024)
Table 36. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2019-2024)
Table 38. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Clinical Oncology Next Generation Sequencing (NGS)
Table 47. Key Market Challenges & Risks of Clinical Oncology Next Generation Sequencing (NGS)
Table 48. Key Industry Trends of Clinical Oncology Next Generation Sequencing (NGS)
Table 49. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Illumina Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 54. Illumina Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 55. Illumina Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Illumina Main Business
Table 57. Illumina Latest Developments
Table 58. Roche Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 59. Roche Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 60. Roche Main Business
Table 61. Roche Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Roche Latest Developments
Table 63. Agilent Technologies Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 64. Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 65. Agilent Technologies Main Business
Table 66. Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Agilent Technologies Latest Developments
Table 68. Knome Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 69. Knome Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 70. Knome Main Business
Table 71. Knome Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Knome Latest Developments
Table 73. Genomatix Software Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 74. Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 75. Genomatix Software Main Business
Table 76. Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Genomatix Software Latest Developments
Table 78. GATC Biotech Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 79. GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 80. GATC Biotech Main Business
Table 81. GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. GATC Biotech Latest Developments
Table 83. Oxford Nanopore Technologies Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 84. Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 85. Oxford Nanopore Technologies Main Business
Table 86. Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Oxford Nanopore Technologies Latest Developments
Table 88. Macrogen Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 89. Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 90. Macrogen Main Business
Table 91. Macrogen Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Macrogen Latest Developments
Table 93. Life Technologies Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 94. Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 95. Life Technologies Main Business
Table 96. Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Life Technologies Latest Developments
Table 98. DNASTAR Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 99. DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 100. DNASTAR Main Business
Table 101. DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. DNASTAR Latest Developments
Table 103. Exosome Diagnostics Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 104. Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 105. Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Exosome Diagnostics Main Business
Table 107. Exosome Diagnostics Latest Developments
Table 108. Biomatters Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 109. Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 110. Biomatters Main Business
Table 111. Biomatters Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Biomatters Latest Developments
Table 113. CLC Bio Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 114. CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 115. CLC Bio Main Business
Table 116. CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. CLC Bio Latest Developments
Table 118. BGI Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 119. BGI Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 120. BGI Main Business
Table 121. BGI Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 122. BGI Latest Developments
Table 123. Qiagen Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 124. Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 125. Qiagen Main Business
Table 126. Qiagen Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 127. Qiagen Latest Developments
Table 128. Perkin Elmer Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 129. Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 130. Perkin Elmer Main Business
Table 131. Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 132. Perkin Elmer Latest Developments
Table 133. Pacific Bioscience Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 134. Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 135. Pacific Bioscience Main Business
Table 136. Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 137. Pacific Bioscience Latest Developments
Table 138. Partek Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 139. Partek Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 140. Partek Main Business
Table 141. Partek Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 142. Partek Latest Developments
Table 143. GnuBIO Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 144. GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 145. GnuBIO Main Business
Table 146. GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 147. GnuBIO Latest Developments
Table 148. Foundation Medicine Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 149. Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 150. Foundation Medicine Main Business
Table 151. Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 152. Foundation Medicine Latest Developments
Table 153. Paradigm Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 154. Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 155. Paradigm Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 156. Paradigm Main Business
Table 157. Paradigm Latest Developments
Table 158. Caris Life Sciences Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 159. Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 160. Caris Life Sciences Main Business
Table 161. Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 162. Caris Life Sciences Latest Developments
Table 163. Myriad Genetics Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 164. Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 165. Myriad Genetics Main Business
Table 166. Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 167. Myriad Genetics Latest Developments
Table 1. Clinical Oncology Next Generation Sequencing (NGS) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of NGS Pre-Sequencing
Table 3. Major Players of Sequencing
Table 4. Major Players of NGS Data Analysis
Table 5. Major Players of Primary, Secondary & Tertiary Data Analysis
Table 6. Clinical Oncology Next Generation Sequencing (NGS) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2019-2024)
Table 9. Clinical Oncology Next Generation Sequencing (NGS) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2019-2024)
Table 12. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Player (2019-2024)
Table 14. Clinical Oncology Next Generation Sequencing (NGS) Key Players Head office and Products Offered
Table 15. Clinical Oncology Next Generation Sequencing (NGS) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Regions (2019-2024)
Table 20. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Country (2019-2024)
Table 24. Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2019-2024)
Table 26. Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2019-2024)
Table 28. APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Region (2019-2024)
Table 30. APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2019-2024)
Table 32. APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2019-2024)
Table 34. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Country (2019-2024)
Table 36. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2019-2024)
Table 38. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Clinical Oncology Next Generation Sequencing (NGS)
Table 47. Key Market Challenges & Risks of Clinical Oncology Next Generation Sequencing (NGS)
Table 48. Key Industry Trends of Clinical Oncology Next Generation Sequencing (NGS)
Table 49. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Illumina Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 54. Illumina Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 55. Illumina Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Illumina Main Business
Table 57. Illumina Latest Developments
Table 58. Roche Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 59. Roche Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 60. Roche Main Business
Table 61. Roche Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Roche Latest Developments
Table 63. Agilent Technologies Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 64. Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 65. Agilent Technologies Main Business
Table 66. Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Agilent Technologies Latest Developments
Table 68. Knome Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 69. Knome Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 70. Knome Main Business
Table 71. Knome Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Knome Latest Developments
Table 73. Genomatix Software Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 74. Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 75. Genomatix Software Main Business
Table 76. Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Genomatix Software Latest Developments
Table 78. GATC Biotech Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 79. GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 80. GATC Biotech Main Business
Table 81. GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. GATC Biotech Latest Developments
Table 83. Oxford Nanopore Technologies Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 84. Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 85. Oxford Nanopore Technologies Main Business
Table 86. Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Oxford Nanopore Technologies Latest Developments
Table 88. Macrogen Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 89. Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 90. Macrogen Main Business
Table 91. Macrogen Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Macrogen Latest Developments
Table 93. Life Technologies Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 94. Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 95. Life Technologies Main Business
Table 96. Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Life Technologies Latest Developments
Table 98. DNASTAR Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 99. DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 100. DNASTAR Main Business
Table 101. DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. DNASTAR Latest Developments
Table 103. Exosome Diagnostics Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 104. Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 105. Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Exosome Diagnostics Main Business
Table 107. Exosome Diagnostics Latest Developments
Table 108. Biomatters Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 109. Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 110. Biomatters Main Business
Table 111. Biomatters Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Biomatters Latest Developments
Table 113. CLC Bio Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 114. CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 115. CLC Bio Main Business
Table 116. CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. CLC Bio Latest Developments
Table 118. BGI Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 119. BGI Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 120. BGI Main Business
Table 121. BGI Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 122. BGI Latest Developments
Table 123. Qiagen Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 124. Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 125. Qiagen Main Business
Table 126. Qiagen Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 127. Qiagen Latest Developments
Table 128. Perkin Elmer Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 129. Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 130. Perkin Elmer Main Business
Table 131. Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 132. Perkin Elmer Latest Developments
Table 133. Pacific Bioscience Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 134. Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 135. Pacific Bioscience Main Business
Table 136. Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 137. Pacific Bioscience Latest Developments
Table 138. Partek Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 139. Partek Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 140. Partek Main Business
Table 141. Partek Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 142. Partek Latest Developments
Table 143. GnuBIO Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 144. GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 145. GnuBIO Main Business
Table 146. GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 147. GnuBIO Latest Developments
Table 148. Foundation Medicine Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 149. Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 150. Foundation Medicine Main Business
Table 151. Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 152. Foundation Medicine Latest Developments
Table 153. Paradigm Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 154. Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 155. Paradigm Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 156. Paradigm Main Business
Table 157. Paradigm Latest Developments
Table 158. Caris Life Sciences Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 159. Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 160. Caris Life Sciences Main Business
Table 161. Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 162. Caris Life Sciences Latest Developments
Table 163. Myriad Genetics Details, Company Type, Clinical Oncology Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 164. Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product Offered
Table 165. Myriad Genetics Main Business
Table 166. Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 167. Myriad Genetics Latest Developments
LIST OF FIGURES
Figure 1. Clinical Oncology Next Generation Sequencing (NGS) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Clinical Oncology Next Generation Sequencing (NGS) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Country/Region (2023)
Figure 8. Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type in 2023
Figure 10. Clinical Oncology Next Generation Sequencing (NGS) in Academic & Clinical Research
Figure 11. Global Clinical Oncology Next Generation Sequencing (NGS) Market: Academic & Clinical Research (2019-2024) & ($ Millions)
Figure 12. Clinical Oncology Next Generation Sequencing (NGS) in Hospitals & Clinics
Figure 13. Global Clinical Oncology Next Generation Sequencing (NGS) Market: Hospitals & Clinics (2019-2024) & ($ Millions)
Figure 14. Clinical Oncology Next Generation Sequencing (NGS) in Pharma & Biotech Entities
Figure 15. Global Clinical Oncology Next Generation Sequencing (NGS) Market: Pharma & Biotech Entities (2019-2024) & ($ Millions)
Figure 16. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application in 2023
Figure 17. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Player in 2023
Figure 18. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size 2019-2024 ($ Millions)
Figure 20. APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size 2019-2024 ($ Millions)
Figure 21. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size 2019-2024 ($ Millions)
Figure 23. Americas Clinical Oncology Next Generation Sequencing (NGS) Value Market Share by Country in 2023
Figure 24. United States Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Region in 2023
Figure 29. APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type in 2023
Figure 30. APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application in 2023
Figure 31. China Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Country in 2023
Figure 38. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2019-2024)
Figure 39. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2019-2024)
Figure 40. Germany Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 54. APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 55. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 57. United States Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 58. Canada Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 61. China Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 62. Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 63. Korea Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 65. India Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 66. Australia Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 67. Germany Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 68. France Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 69. UK Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 70. Italy Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 71. Russia Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 72. Spain Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 75. Israel Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 78. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Clinical Oncology Next Generation Sequencing (NGS) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Clinical Oncology Next Generation Sequencing (NGS) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Country/Region (2023)
Figure 8. Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type in 2023
Figure 10. Clinical Oncology Next Generation Sequencing (NGS) in Academic & Clinical Research
Figure 11. Global Clinical Oncology Next Generation Sequencing (NGS) Market: Academic & Clinical Research (2019-2024) & ($ Millions)
Figure 12. Clinical Oncology Next Generation Sequencing (NGS) in Hospitals & Clinics
Figure 13. Global Clinical Oncology Next Generation Sequencing (NGS) Market: Hospitals & Clinics (2019-2024) & ($ Millions)
Figure 14. Clinical Oncology Next Generation Sequencing (NGS) in Pharma & Biotech Entities
Figure 15. Global Clinical Oncology Next Generation Sequencing (NGS) Market: Pharma & Biotech Entities (2019-2024) & ($ Millions)
Figure 16. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application in 2023
Figure 17. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Player in 2023
Figure 18. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size 2019-2024 ($ Millions)
Figure 20. APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size 2019-2024 ($ Millions)
Figure 21. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size 2019-2024 ($ Millions)
Figure 23. Americas Clinical Oncology Next Generation Sequencing (NGS) Value Market Share by Country in 2023
Figure 24. United States Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Region in 2023
Figure 29. APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type in 2023
Figure 30. APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application in 2023
Figure 31. China Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Country in 2023
Figure 38. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2019-2024)
Figure 39. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2019-2024)
Figure 40. Germany Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 54. APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 55. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 57. United States Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 58. Canada Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 61. China Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 62. Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 63. Korea Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 65. India Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 66. Australia Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 67. Germany Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 68. France Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 69. UK Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 70. Italy Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 71. Russia Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 72. Spain Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 75. Israel Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Clinical Oncology Next Generation Sequencing (NGS) Market Size 2025-2030 ($ Millions)
Figure 78. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share Forecast by Application (2025-2030)
